Transcription of DRUG SUBSTANCE: DEFINING REGULATORY …
{{id}} {{{paragraph}}}
CONFIDENTIAL 2015 PAREXEL INTERNATIONAL CORP. drug substance : DEFINING REGULATORY starting MATERIALS June 9th, 2015 Aloka Srinivasan, , Principal Consultant 2015 PAREXEL INTERNATIONAL CORP. / CONFIDENTIAL 2 BOSTON, MASSACHUSETTS 2 INTRODUCTION 2015 PAREXEL INTERNATIONAL CORP. / CONFIDENTIAL 3 In recent years, there has been a steep rise in the number of questions asked about the choice of REGULATORY starting Materials (RSM) for Active Pharmaceutical Ingredients (APIs) from FDA as well as other REGULATORY agencies in the world. REGULATORY authorities are worried that the RSM is shifting more and more towards the API, which has the probability of causing significant risk to API quality, and may also lead to problems in life cycle management.
CONFIDENTIAL © 2015 PAREXEL INTERNATIONAL CORP. DRUG SUBSTANCE: DEFINING REGULATORY STARTING MATERIALS June 9th, 2015 Aloka Srinivasan, Ph.D., Principal Consultant
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
Analytical Method Selection for Drug Product, Analytical Method Selection for Drug Product Dissolution, Chapter-2 Analytical Method Development and, Analytical Method Development and Validation, Drug product, Q1A(R2) Guideline Stability Testing of New, Q1A(R2) Guideline Stability Testing of New Drug, ANALYTICAL METHOD, CHROMATOGRAPHIC METHOD FOR THE ESTIMATION, Fao animal production and health, PHARMACEUTICAL DEVELOPMENT FOR, PHARMACEUTICAL DEVELOPMENT FOR MULTISOURCE (GENERIC) PHARMACEUTICAL